These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30733251)

  • 1. Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate.
    Barr JT; Lade JM; Tran TB; Dahal UP
    Drug Metab Dispos; 2019 Apr; 47(4):419-423. PubMed ID: 30733251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific binding of compounds in
    Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S
    Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines.
    Riccardi K; Ryu S; Lin J; Yates P; Tess D; Li R; Singh D; Holder BR; Kapinos B; Chang G; Di L
    Drug Metab Dispos; 2018 Apr; 46(4):415-421. PubMed ID: 29437874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules.
    Trunzer M; Teigão J; Huth F; Poller B; Desrayaud S; Rodríguez-Pérez R; Faller B
    Drug Metab Dispos; 2024 Apr; 52(5):345-354. PubMed ID: 38360916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the total body clearance of lead compounds in the rat and mouse: impact on pharmacokinetic screening strategy.
    McIntyre TA; Han C; Xiang H; Bambal R; Davis CB
    Xenobiotica; 2008 Jun; 38(6):605-19. PubMed ID: 18570161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2-p53 interaction, in rats, dogs and monkeys: in vitro-in vivo correlation.
    Ye Q; Jiang M; Huang WT; Ling Y; Olson SH; Sun D; Xu G; Yan X; Wong BK; Jin L
    Xenobiotica; 2015; 45(8):681-92. PubMed ID: 25798742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of appreciable species differences in nonspecific microsomal binding.
    Zhang Y; Yao L; Lin J; Gao H; Wilson TC; Giragossian C
    J Pharm Sci; 2010 Aug; 99(8):3620-7. PubMed ID: 20229604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes.
    Baughman TM; Talarico CL; Soglia JR
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2146-50. PubMed ID: 19517456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
    Brown HS; Griffin M; Houston JB
    Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability.
    Richardson SJ; Bai A; Kulkarni AA; Moghaddam MF
    Drug Metab Lett; 2016; 10(2):83-90. PubMed ID: 26902079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA).
    Rioux N; Smith S; Korpal M; O'Shea M; Prajapati S; Zheng GZ; Warmuth M; Smith PG
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):151-160. PubMed ID: 30386887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
    Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
    Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
    Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.